Protamine Dosage Based on Two Titrations Reduces Blood Loss After Valve Replacement Surgery: A Prospective, Double-Blinded, Randomized Study

Abstract Background Postoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and heparin. We hypothesized that a 2-titration-guided protamine dose would reduce protamine-heparin mismatch and bleeding in those patients. Met...

Full description

Saved in:
Bibliographic Details
Published inCanadian journal of cardiology Vol. 28; no. 5; pp. 547 - 552
Main Authors Guo, Yan, MD, Tang, Jiali, MD, Du, Lei, MD, PhD, Liu, Jin, MD, PhD, Liu, Raphael C., MD, Liu, Xiang, PhD, Guo, Yingqiang, MD
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.09.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background Postoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and heparin. We hypothesized that a 2-titration-guided protamine dose would reduce protamine-heparin mismatch and bleeding in those patients. Methods Patients scheduled for elective cardiac valve replacement surgery (N = 60) were randomly divided into 3 groups. All patients received 2 titrations: the first at termination of cardiopulmonary bypass and the second at 5 minutes after the initial dose of protamine. In the control group, the initial protamine dose was based on the heparin dose received; the supplemental protamine dose was empirically determined. In the single-titration group, the initial dose was based on the first titration, while supplemental dose was empirically determined. In the 2-titration group, both initial and supplemental doses were based on titrations. Bleeding volumes were recorded from the time of first protamine dose to 24 hours after surgery. Results Most patients needed supplemental protamine according to second titrations. In the 2-titration group, 12 patients received supplemental protamine, whereas only 1 patient in the single-titration group and 6 in the control group received supplemental protamine ( P = 0.003). The blood loss was significantly less in the 2-titration group (526 ± 131 mL) than in the control group (730 ± 385 mL; P = 0.019). Conclusions A higher dosage of protamine based on 2 titrations reduced blood loss after surgery, supporting the hypothesis that inadequate dosage of protamine contributes to hemorrhage after valve replacement surgery.
AbstractList Postoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and heparin. We hypothesized that a 2-titration-guided protamine dose would reduce protamine-heparin mismatch and bleeding in those patients. Patients scheduled for elective cardiac valve replacement surgery (N = 60) were randomly divided into 3 groups. All patients received 2 titrations: the first at termination of cardiopulmonary bypass and the second at 5 minutes after the initial dose of protamine. In the control group, the initial protamine dose was based on the heparin dose received; the supplemental protamine dose was empirically determined. In the single-titration group, the initial dose was based on the first titration, while supplemental dose was empirically determined. In the 2-titration group, both initial and supplemental doses were based on titrations. Bleeding volumes were recorded from the time of first protamine dose to 24 hours after surgery. Most patients needed supplemental protamine according to second titrations. In the 2-titration group, 12 patients received supplemental protamine, whereas only 1 patient in the single-titration group and 6 in the control group received supplemental protamine (P = 0.003). The blood loss was significantly less in the 2-titration group (526 ± 131 mL) than in the control group (730 ± 385 mL; P = 0.019). A higher dosage of protamine based on 2 titrations reduced blood loss after surgery, supporting the hypothesis that inadequate dosage of protamine contributes to hemorrhage after valve replacement surgery. L'hémorragie postopératoire après le pontage cardiopulmonaire chez les patients subissant le remplacement d'une valvule cardiaque peut être causée par une mauvaise combinaison de la protamine et de l'héparine. Nous avons posé l'hypothèse qu'une dose de protamine déterminée par 2 titrages pourrait réduire la mauvaise combinaison protamine-héparine et l'hémorragie chez ces patients. Les patients inscrits à une chirurgie élective de remplacement d'une valvule cardiaque (N = 60) ont été divisés au hasard en 3 groupes. Tous les patients ont eu 2 titrages : le premier à la fin du pontage cardiopulmonaire et le deuxième 5 minutes après la dose initiale de protamine. Dans le groupe témoin, la dose initiale de protamine était basée sur la dose d'héparine reçue; la dose supplémentaire de protamine était déterminée de manière empirique. Dans le groupe à titrage unique, la dose initiale était basée sur le premier titrage, tandis que la dose supplémentaire était déterminée de manière empirique. Dans le groupe à 2 titrages, les doses initiales et supplémentaires étaient basées sur les titrages. Les volumes hémorragiques ont été enregistrés de la première dose de protamine à la dose 24 heures après la chirurgie. La plupart des patients ont eu besoin de protamine supplémentaire selon les deuxièmes titrages. Dans le groupe à 2 titrages, 12 patients ont reçu la protamine supplémentaire, alors que seul 1 patient du groupe à titrage unique et 6 du groupe témoin ont reçu la protamine supplémentaire (P = 0,003). La perte sanguine a été significativement inférieure dans le groupe à 2 titrages (526 ± 131 ml) que dans le groupe témoin (730 ± 385 ml; P = 0,019). Un dosage plus élevé de protamine basé sur 2 titrages a réduit la perte sanguine après la chirurgie, ce qui soutient l'hypothèse qu'une posologie inadéquate de protamine contribue à l'hémorragie après la chirurgie de remplacement valvulaire.
Postoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and heparin. We hypothesized that a 2-titration-guided protamine dose would reduce protamine-heparin mismatch and bleeding in those patients. Patients scheduled for elective cardiac valve replacement surgery (N = 60) were randomly divided into 3 groups. All patients received 2 titrations: the first at termination of cardiopulmonary bypass and the second at 5 minutes after the initial dose of protamine. In the control group, the initial protamine dose was based on the heparin dose received; the supplemental protamine dose was empirically determined. In the single-titration group, the initial dose was based on the first titration, while supplemental dose was empirically determined. In the 2-titration group, both initial and supplemental doses were based on titrations. Bleeding volumes were recorded from the time of first protamine dose to 24 hours after surgery. Most patients needed supplemental protamine according to second titrations. In the 2-titration group, 12 patients received supplemental protamine, whereas only 1 patient in the single-titration group and 6 in the control group received supplemental protamine (P = 0.003). The blood loss was significantly less in the 2-titration group (526 ± 131 mL) than in the control group (730 ± 385 mL; P = 0.019). A higher dosage of protamine based on 2 titrations reduced blood loss after surgery, supporting the hypothesis that inadequate dosage of protamine contributes to hemorrhage after valve replacement surgery.
BACKGROUNDPostoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and heparin. We hypothesized that a 2-titration-guided protamine dose would reduce protamine-heparin mismatch and bleeding in those patients.METHODSPatients scheduled for elective cardiac valve replacement surgery (N = 60) were randomly divided into 3 groups. All patients received 2 titrations: the first at termination of cardiopulmonary bypass and the second at 5 minutes after the initial dose of protamine. In the control group, the initial protamine dose was based on the heparin dose received; the supplemental protamine dose was empirically determined. In the single-titration group, the initial dose was based on the first titration, while supplemental dose was empirically determined. In the 2-titration group, both initial and supplemental doses were based on titrations. Bleeding volumes were recorded from the time of first protamine dose to 24 hours after surgery.RESULTSMost patients needed supplemental protamine according to second titrations. In the 2-titration group, 12 patients received supplemental protamine, whereas only 1 patient in the single-titration group and 6 in the control group received supplemental protamine (P = 0.003). The blood loss was significantly less in the 2-titration group (526 ± 131 mL) than in the control group (730 ± 385 mL; P = 0.019).CONCLUSIONSA higher dosage of protamine based on 2 titrations reduced blood loss after surgery, supporting the hypothesis that inadequate dosage of protamine contributes to hemorrhage after valve replacement surgery.
Abstract Background Postoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and heparin. We hypothesized that a 2-titration-guided protamine dose would reduce protamine-heparin mismatch and bleeding in those patients. Methods Patients scheduled for elective cardiac valve replacement surgery (N = 60) were randomly divided into 3 groups. All patients received 2 titrations: the first at termination of cardiopulmonary bypass and the second at 5 minutes after the initial dose of protamine. In the control group, the initial protamine dose was based on the heparin dose received; the supplemental protamine dose was empirically determined. In the single-titration group, the initial dose was based on the first titration, while supplemental dose was empirically determined. In the 2-titration group, both initial and supplemental doses were based on titrations. Bleeding volumes were recorded from the time of first protamine dose to 24 hours after surgery. Results Most patients needed supplemental protamine according to second titrations. In the 2-titration group, 12 patients received supplemental protamine, whereas only 1 patient in the single-titration group and 6 in the control group received supplemental protamine ( P = 0.003). The blood loss was significantly less in the 2-titration group (526 ± 131 mL) than in the control group (730 ± 385 mL; P = 0.019). Conclusions A higher dosage of protamine based on 2 titrations reduced blood loss after surgery, supporting the hypothesis that inadequate dosage of protamine contributes to hemorrhage after valve replacement surgery.
Author Liu, Xiang, PhD
Guo, Yan, MD
Tang, Jiali, MD
Liu, Jin, MD, PhD
Du, Lei, MD, PhD
Liu, Raphael C., MD
Guo, Yingqiang, MD
Author_xml – sequence: 1
  fullname: Guo, Yan, MD
– sequence: 2
  fullname: Tang, Jiali, MD
– sequence: 3
  fullname: Du, Lei, MD, PhD
– sequence: 4
  fullname: Liu, Jin, MD, PhD
– sequence: 5
  fullname: Liu, Raphael C., MD
– sequence: 6
  fullname: Liu, Xiang, PhD
– sequence: 7
  fullname: Guo, Yingqiang, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22633184$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk2P0zAUtNAitrvwBzggHzlsgj8SJ0FopXb5lCqBtgVxs1z7ZeWQ2MVOispv4EfjqAsHDpzm8Gbm6c28C3TmvAOEnlKSU0LFiy7XnVY5I5TlhOcJHqAFbajIKlKVZ2hBalZnrGZfz9FFjB0hBa0q8QidMyY4p3WxQL8-BT-qwTrAr31Ud4BXKoLB3uHtD4-3dgxqtN5FfAtm0hDxqvfe4LWPES_bEQL-ovoDpPG-VxoGcCPeTOEOwvElXuJkH_egR3uAq7Rh2vWQrXrrDJgrfKuc8YP9mfZtxskcH6OHreojPLnHS_T57Zvtzfts_fHdh5vlOtMFpWMGFZRFS9SO86YqmNmBMaQUdS3SVaRqWiJ2homq5HXZNDVrQZAKgJSGl6UyJb9Ez0----C_TxBHOdiooe-VAz9FSYloGKlL0SQqO1F1OiQGaOU-2EGFYyLJuQXZybkFObcgCZcJkujZvf-0G8D8lfyJPRFenQiQrjxYCDJqC06DsSGFJY23__e__keuU6RWq_4bHCF2fgou5SepjEkjN_MfzG9AGSG0Yg3_DaiTr1k
CitedBy_id crossref_primary_10_1007_s11748_021_01709_y
crossref_primary_10_3389_fcvm_2022_1060283
crossref_primary_10_1016_j_jcin_2020_03_041
crossref_primary_10_1097_MD_0000000000014219
crossref_primary_10_1097_EJA_0000000000000630
crossref_primary_10_1160_TH16_02_0117
crossref_primary_10_1038_s41598_019_49253_3
crossref_primary_10_1097_EJA_0000000000001803
crossref_primary_10_1213_ANE_0000000000002613
crossref_primary_10_1213_ANE_0000000000004528
crossref_primary_10_1097_MD_0000000000003424
crossref_primary_10_1016_j_athoracsur_2017_09_061
crossref_primary_10_1051_ject_201850005
crossref_primary_10_21320_1818_474X_2021_3_7_26
crossref_primary_10_1002_clc_23936
Cites_doi 10.1016/S0022-5223(19)41499-2
10.1053/j.jvca.2007.07.011
10.1111/j.1365-2044.1983.tb13988.x
10.1097/00000542-200210000-00014
10.1016/0006-291X(83)90550-8
10.1378/chest.108.4_Supplement.258S
10.1016/S0022-5223(97)70380-5
10.1001/archsurg.1994.01420330059012
10.1182/blood.V76.9.1680.1680
10.1053/scva.2001.26127
10.1016/S0022-5223(19)34841-X
10.1002/ajh.2830140304
10.1182/blood-2009-05-222109
10.1055/s-2007-1013166
10.1046/j.1365-2141.2001.03100.x
10.1016/S0022-5223(99)70227-8
10.1016/S0022-5223(05)80008-X
ContentType Journal Article
Copyright Canadian Cardiovascular Society
2012 Canadian Cardiovascular Society
Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Canadian Cardiovascular Society
– notice: 2012 Canadian Cardiovascular Society
– notice: Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.cjca.2012.03.012
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1916-7075
EndPage 552
ExternalDocumentID 10_1016_j_cjca_2012_03_012
22633184
S0828282X12001729
1_s2_0_S0828282X12001729
Genre Comparative Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1P~
1~.
1~5
29B
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
8P~
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXKI
AAXUO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFO
ACJTP
ACRLP
ADBBV
ADEZE
ADMUD
ADVLN
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXBA
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
E3Z
EBS
EFJIC
EJD
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HX~
HYE
HZ~
J1W
KOM
M41
MO0
O-L
O9-
OAUVE
OA~
OK1
OL0
P-8
P-9
P2P
PC.
Q38
ROL
RPM
SDF
SEL
SES
SJN
SNG
SPCBC
SSH
SSZ
T5K
TR2
Z5R
~G-
AAIAV
ABLVK
ABYKQ
AISVY
AJBFU
EFLBG
LCYCR
NAHTW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c411t-e7e54f0ab339742dbedd056886633079f06bd26753859982fe607ee05d355ad53
IEDL.DBID .~1
ISSN 0828-282X
IngestDate Fri Aug 16 02:10:21 EDT 2024
Thu Sep 26 17:50:43 EDT 2024
Sat Sep 28 07:52:09 EDT 2024
Fri Feb 23 02:17:26 EST 2024
Tue Oct 15 22:57:01 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c411t-e7e54f0ab339742dbedd056886633079f06bd26753859982fe607ee05d355ad53
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
PMID 22633184
PQID 1069208569
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1069208569
crossref_primary_10_1016_j_cjca_2012_03_012
pubmed_primary_22633184
elsevier_sciencedirect_doi_10_1016_j_cjca_2012_03_012
elsevier_clinicalkeyesjournals_1_s2_0_S0828282X12001729
PublicationCentury 2000
PublicationDate 2012-09-01
PublicationDateYYYYMMDD 2012-09-01
PublicationDate_xml – month: 09
  year: 2012
  text: 2012-09-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Canadian journal of cardiology
PublicationTitleAlternate Can J Cardiol
PublicationYear 2012
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Beholz, Grubitzsch, Bergmann, Wollert, Eckel (bib17) 1999; 47
Khuri, Wolfe, Josa (bib3) 1992; 104
Perkins, Osborn, Hurt, Gerbode (bib22) 1956; 48
Choay, Petitou, Lormeau, Sinay, Casu, Gatti (bib7) 1983; 116
Despotis, Joist, Hogue (bib15) 1995; 110
Ni Ainle, Preston, Jenkins (bib11) 2009; 114
Tang, Li, Du, Liu (bib19) 2010; 17
Runge, Moller, Steinbrüchel (bib24) 2009; 41
Slight, Buell, Nzewi, McClelland, Mankad (bib23) 2008; 22
Shigeta, Kojima, Hiramatsu (bib13) 1999; 118
Dutton, Hothersall, Mclaren, Taylor, Turner (bib18) 1983; 38
Rosen, Casoni (bib5) 2001; 20
Hirsh, Raschke, Warkentin, Dalen, Deykin, Poller (bib8) 1995; 108
Newsome, Stipanovich, Flaherty (bib16) 2004; 36
Woodman, Harker (bib1) 1990; 76
Fang, Shi, Zhang, Dong (bib20) 2005; 12
Cobel-Geard, Hassouna (bib9) 1983; 14
Despotis, Joist, Goodnough, Santoto, Spitznagel (bib12) 1997; 113
Bull, Huse, Brauer, Korpman (bib6) 1975; 69
Skubas, Despotis (bib2) 2001; 5
Koster, Fischer, Praus (bib14) 2002; 97
DeLaria, Tyner, Hayes, Armstrong (bib4) 1994; 129
Luo (bib21) 2004
Chu, Wang, Raicu, Beydoun, Ramos (bib10) 2001; 115
Beholz (10.1016/j.cjca.2012.03.012_bib17) 1999; 47
Woodman (10.1016/j.cjca.2012.03.012_bib1) 1990; 76
Tang (10.1016/j.cjca.2012.03.012_bib19) 2010; 17
DeLaria (10.1016/j.cjca.2012.03.012_bib4) 1994; 129
Chu (10.1016/j.cjca.2012.03.012_bib10) 2001; 115
Slight (10.1016/j.cjca.2012.03.012_bib23) 2008; 22
Despotis (10.1016/j.cjca.2012.03.012_bib15) 1995; 110
Runge (10.1016/j.cjca.2012.03.012_bib24) 2009; 41
Ni Ainle (10.1016/j.cjca.2012.03.012_bib11) 2009; 114
Koster (10.1016/j.cjca.2012.03.012_bib14) 2002; 97
Skubas (10.1016/j.cjca.2012.03.012_bib2) 2001; 5
Despotis (10.1016/j.cjca.2012.03.012_bib12) 1997; 113
Choay (10.1016/j.cjca.2012.03.012_bib7) 1983; 116
Cobel-Geard (10.1016/j.cjca.2012.03.012_bib9) 1983; 14
Shigeta (10.1016/j.cjca.2012.03.012_bib13) 1999; 118
Dutton (10.1016/j.cjca.2012.03.012_bib18) 1983; 38
Rosen (10.1016/j.cjca.2012.03.012_bib5) 2001; 20
Bull (10.1016/j.cjca.2012.03.012_bib6) 1975; 69
Luo (10.1016/j.cjca.2012.03.012_bib21) 2004
Perkins (10.1016/j.cjca.2012.03.012_bib22) 1956; 48
Khuri (10.1016/j.cjca.2012.03.012_bib3) 1992; 104
Hirsh (10.1016/j.cjca.2012.03.012_bib8) 1995; 108
Newsome (10.1016/j.cjca.2012.03.012_bib16) 2004; 36
Fang (10.1016/j.cjca.2012.03.012_bib20) 2005; 12
References_xml – volume: 110
  start-page: 46
  year: 1995
  end-page: 54
  ident: bib15
  article-title: The impact of heparin concentration and activated clotting time monitoring on blood conservation: a prospective, randomized evaluation in patients undergoing cardiac operation
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Hogue
– volume: 76
  start-page: 1680
  year: 1990
  end-page: 1697
  ident: bib1
  article-title: Bleeding complications associated with cardiopulmonary bypass
  publication-title: Blood
  contributor:
    fullname: Harker
– volume: 129
  start-page: 945
  year: 1994
  end-page: 951
  ident: bib4
  article-title: Heparin-protamine mismatch: a controllable factor in bleeding after open heart surgery
  publication-title: Arch Surg
  contributor:
    fullname: Armstrong
– volume: 41
  start-page: 10
  year: 2009
  end-page: 14
  ident: bib24
  publication-title: Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study
  contributor:
    fullname: Steinbrüchel
– volume: 115
  start-page: 392
  year: 2001
  end-page: 399
  ident: bib10
  article-title: Protamine inhibits tissue factor-initiated extrinsic coagulation
  publication-title: Br J Haematol
  contributor:
    fullname: Ramos
– volume: 22
  start-page: 47
  year: 2008
  end-page: 52
  ident: bib23
  article-title: A comparison of activated coagulation time–based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass
  publication-title: J Cardiothor Vasc An
  contributor:
    fullname: Mankad
– volume: 116
  start-page: 492
  year: 1983
  end-page: 499
  ident: bib7
  article-title: Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
  publication-title: Biochem Biophys Res Commun
  contributor:
    fullname: Gatti
– volume: 5
  start-page: 217
  year: 2001
  end-page: 228
  ident: bib2
  article-title: Optimal management of bleeding complications after cardiac surgery
  publication-title: Semin Cardiothorac Vasc Anesth
  contributor:
    fullname: Despotis
– volume: 69
  start-page: 674
  year: 1975
  end-page: 684
  ident: bib6
  article-title: Heparin therapy during extracorporeal circulation: I: problems inherent in existing heparin protocols
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Korpman
– volume: 118
  start-page: 354
  year: 1999
  end-page: 360
  ident: bib13
  article-title: Low-dose protamine based on heparin–protamine titration method reduces platelet dysfunction after cardiopulmonary bypass
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Hiramatsu
– volume: 12
  start-page: 1002
  year: 2005
  end-page: 1004
  ident: bib20
  article-title: Clinical study of different dose protamine reversal of heparin in open heart surgery
  publication-title: Chin J Clin Med
  contributor:
    fullname: Dong
– volume: 47
  start-page: 322
  year: 1999
  end-page: 327
  ident: bib17
  article-title: Haemostasis management by use of the Hepcon/HMS: increased bleeding without increased need for blood transfusion
  publication-title: Thorac Cardiovasc Surgeon
  contributor:
    fullname: Eckel
– volume: 36
  start-page: 139
  year: 2004
  end-page: 144
  ident: bib16
  article-title: Comparison of heparin administration using the Rapidpoint Coag and Hepcon/HMS
  publication-title: J Extra-Corporeal Technol
  contributor:
    fullname: Flaherty
– volume: 108
  start-page: 258S
  year: 1995
  end-page: 275S
  ident: bib8
  article-title: Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
  publication-title: Chest
  contributor:
    fullname: Poller
– volume: 20
  start-page: 35
  year: 2001
  end-page: 38
  ident: bib5
  article-title: Heparin therapy and monitoring: a role for the chromogenic antifactor Xa assay
  publication-title: Am Clin Lab
  contributor:
    fullname: Casoni
– volume: 97
  start-page: 837
  year: 2002
  end-page: 841
  ident: bib14
  article-title: Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management
  publication-title: Anesthesiology
  contributor:
    fullname: Praus
– start-page: 46
  year: 2004
  end-page: 47
  ident: bib21
  article-title: Blood
  publication-title: Physiology
  contributor:
    fullname: Luo
– volume: 17
  start-page: 104
  year: 2010
  end-page: 108
  ident: bib19
  article-title: Protamine reduces postoperative blood loss after open heart surgery undergoing cardiopulmonary bypass
  publication-title: Chin J Clin Thorac Cardiovasc Surg
  contributor:
    fullname: Liu
– volume: 14
  start-page: 227
  year: 1983
  end-page: 233
  ident: bib9
  article-title: Interaction of protamine sulfate with thrombin
  publication-title: Am J Hematol
  contributor:
    fullname: Hassouna
– volume: 104
  start-page: 94
  year: 1992
  end-page: 107
  ident: bib3
  article-title: Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Josa
– volume: 114
  start-page: 1658
  year: 2009
  end-page: 1665
  ident: bib11
  article-title: Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation
  publication-title: Blood
  contributor:
    fullname: Jenkins
– volume: 38
  start-page: 264
  year: 1983
  end-page: 268
  ident: bib18
  article-title: Protamine titration after cardiopulmonary bypass
  publication-title: Anaesthesia
  contributor:
    fullname: Turner
– volume: 113
  start-page: 611
  year: 1997
  end-page: 613
  ident: bib12
  article-title: Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Spitznagel
– volume: 48
  start-page: 223
  year: 1956
  end-page: 226
  ident: bib22
  article-title: Neutralization of heparin in vivo with protamine: a simple method of estimating the required dose
  publication-title: J Lab Clin Med
  contributor:
    fullname: Gerbode
– volume: 69
  start-page: 674
  year: 1975
  ident: 10.1016/j.cjca.2012.03.012_bib6
  article-title: Heparin therapy during extracorporeal circulation: I: problems inherent in existing heparin protocols
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/S0022-5223(19)41499-2
  contributor:
    fullname: Bull
– volume: 22
  start-page: 47
  year: 2008
  ident: 10.1016/j.cjca.2012.03.012_bib23
  article-title: A comparison of activated coagulation time–based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass
  publication-title: J Cardiothor Vasc An
  doi: 10.1053/j.jvca.2007.07.011
  contributor:
    fullname: Slight
– volume: 38
  start-page: 264
  year: 1983
  ident: 10.1016/j.cjca.2012.03.012_bib18
  article-title: Protamine titration after cardiopulmonary bypass
  publication-title: Anaesthesia
  doi: 10.1111/j.1365-2044.1983.tb13988.x
  contributor:
    fullname: Dutton
– volume: 17
  start-page: 104
  year: 2010
  ident: 10.1016/j.cjca.2012.03.012_bib19
  article-title: Protamine reduces postoperative blood loss after open heart surgery undergoing cardiopulmonary bypass
  publication-title: Chin J Clin Thorac Cardiovasc Surg
  contributor:
    fullname: Tang
– start-page: 46
  year: 2004
  ident: 10.1016/j.cjca.2012.03.012_bib21
  article-title: Blood
  contributor:
    fullname: Luo
– volume: 97
  start-page: 837
  year: 2002
  ident: 10.1016/j.cjca.2012.03.012_bib14
  article-title: Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management
  publication-title: Anesthesiology
  doi: 10.1097/00000542-200210000-00014
  contributor:
    fullname: Koster
– volume: 116
  start-page: 492
  year: 1983
  ident: 10.1016/j.cjca.2012.03.012_bib7
  article-title: Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/0006-291X(83)90550-8
  contributor:
    fullname: Choay
– volume: 48
  start-page: 223
  year: 1956
  ident: 10.1016/j.cjca.2012.03.012_bib22
  article-title: Neutralization of heparin in vivo with protamine: a simple method of estimating the required dose
  publication-title: J Lab Clin Med
  contributor:
    fullname: Perkins
– volume: 108
  start-page: 258S
  year: 1995
  ident: 10.1016/j.cjca.2012.03.012_bib8
  article-title: Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
  publication-title: Chest
  doi: 10.1378/chest.108.4_Supplement.258S
  contributor:
    fullname: Hirsh
– volume: 12
  start-page: 1002
  year: 2005
  ident: 10.1016/j.cjca.2012.03.012_bib20
  article-title: Clinical study of different dose protamine reversal of heparin in open heart surgery
  publication-title: Chin J Clin Med
  contributor:
    fullname: Fang
– volume: 113
  start-page: 611
  year: 1997
  ident: 10.1016/j.cjca.2012.03.012_bib12
  article-title: Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/S0022-5223(97)70380-5
  contributor:
    fullname: Despotis
– volume: 36
  start-page: 139
  year: 2004
  ident: 10.1016/j.cjca.2012.03.012_bib16
  article-title: Comparison of heparin administration using the Rapidpoint Coag and Hepcon/HMS
  publication-title: J Extra-Corporeal Technol
  contributor:
    fullname: Newsome
– volume: 129
  start-page: 945
  year: 1994
  ident: 10.1016/j.cjca.2012.03.012_bib4
  article-title: Heparin-protamine mismatch: a controllable factor in bleeding after open heart surgery
  publication-title: Arch Surg
  doi: 10.1001/archsurg.1994.01420330059012
  contributor:
    fullname: DeLaria
– volume: 20
  start-page: 35
  year: 2001
  ident: 10.1016/j.cjca.2012.03.012_bib5
  article-title: Heparin therapy and monitoring: a role for the chromogenic antifactor Xa assay
  publication-title: Am Clin Lab
  contributor:
    fullname: Rosen
– volume: 76
  start-page: 1680
  year: 1990
  ident: 10.1016/j.cjca.2012.03.012_bib1
  article-title: Bleeding complications associated with cardiopulmonary bypass
  publication-title: Blood
  doi: 10.1182/blood.V76.9.1680.1680
  contributor:
    fullname: Woodman
– volume: 5
  start-page: 217
  year: 2001
  ident: 10.1016/j.cjca.2012.03.012_bib2
  article-title: Optimal management of bleeding complications after cardiac surgery
  publication-title: Semin Cardiothorac Vasc Anesth
  doi: 10.1053/scva.2001.26127
  contributor:
    fullname: Skubas
– volume: 41
  start-page: 10
  year: 2009
  ident: 10.1016/j.cjca.2012.03.012_bib24
  publication-title: Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study
  contributor:
    fullname: Runge
– volume: 104
  start-page: 94
  year: 1992
  ident: 10.1016/j.cjca.2012.03.012_bib3
  article-title: Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/S0022-5223(19)34841-X
  contributor:
    fullname: Khuri
– volume: 14
  start-page: 227
  year: 1983
  ident: 10.1016/j.cjca.2012.03.012_bib9
  article-title: Interaction of protamine sulfate with thrombin
  publication-title: Am J Hematol
  doi: 10.1002/ajh.2830140304
  contributor:
    fullname: Cobel-Geard
– volume: 114
  start-page: 1658
  year: 2009
  ident: 10.1016/j.cjca.2012.03.012_bib11
  article-title: Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation
  publication-title: Blood
  doi: 10.1182/blood-2009-05-222109
  contributor:
    fullname: Ni Ainle
– volume: 47
  start-page: 322
  year: 1999
  ident: 10.1016/j.cjca.2012.03.012_bib17
  article-title: Haemostasis management by use of the Hepcon/HMS: increased bleeding without increased need for blood transfusion
  publication-title: Thorac Cardiovasc Surgeon
  doi: 10.1055/s-2007-1013166
  contributor:
    fullname: Beholz
– volume: 115
  start-page: 392
  year: 2001
  ident: 10.1016/j.cjca.2012.03.012_bib10
  article-title: Protamine inhibits tissue factor-initiated extrinsic coagulation
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2001.03100.x
  contributor:
    fullname: Chu
– volume: 118
  start-page: 354
  year: 1999
  ident: 10.1016/j.cjca.2012.03.012_bib13
  article-title: Low-dose protamine based on heparin–protamine titration method reduces platelet dysfunction after cardiopulmonary bypass
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/S0022-5223(99)70227-8
  contributor:
    fullname: Shigeta
– volume: 110
  start-page: 46
  year: 1995
  ident: 10.1016/j.cjca.2012.03.012_bib15
  article-title: The impact of heparin concentration and activated clotting time monitoring on blood conservation: a prospective, randomized evaluation in patients undergoing cardiac operation
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/S0022-5223(05)80008-X
  contributor:
    fullname: Despotis
SSID ssj0041776
Score 2.1322455
Snippet Abstract Background Postoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and...
Postoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and heparin. We...
BACKGROUNDPostoperative hemorrhage following cardiopulmonary bypass in heart valve replacement patients may be caused by a mismatch of protamine and heparin....
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 547
SubjectTerms Adult
Cardiopulmonary Bypass - adverse effects
Cardiopulmonary Bypass - methods
Cardiovascular
Chi-Square Distribution
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Heart Valve Prosthesis Implantation - adverse effects
Heart Valve Prosthesis Implantation - methods
Heparin - administration & dosage
Heparin - adverse effects
Heparin Antagonists - administration & dosage
Humans
Male
Middle Aged
Postoperative Hemorrhage - drug therapy
Postoperative Hemorrhage - prevention & control
Prospective Studies
Protamines - administration & dosage
Reference Values
Risk Assessment
Treatment Outcome
Title Protamine Dosage Based on Two Titrations Reduces Blood Loss After Valve Replacement Surgery: A Prospective, Double-Blinded, Randomized Study
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0828282X12001729
https://dx.doi.org/10.1016/j.cjca.2012.03.012
https://www.ncbi.nlm.nih.gov/pubmed/22633184
https://search.proquest.com/docview/1069208569
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemISFeEOOzMCYj8ca8Jo6dD97awlRgTFPXob5ZcXyROnXJtLQgeOAv4I_mLnEqITQeUKR8Ojknd7k72787M_baOVlEypXCalcIlapQ5MhmoTJrrc7jLO0Asqfx9EJ9XOjFDpv0sTAEq_S6v9Pprbb2Z4b-aw6vl8vhOSVfw2URyrYhQ0F8Co0RyvTRzy3MQ4VJO8EcFRZU2gfOdBiv4rKg3EPUHxgdBaG8zTjd5ny2Ruj4AbvvvUc-6iq4x3agesjufvbj44_Yr7Obep1f4T5_VxNkjI_RSjleV3z-rebzpU-S2_AZpWyFho8JuM5PsDZ8RNOF8y_56ivg5RasRV2H_LyLnH7LRxwf34dmHiKFjV2BGK8o46I75LO8cvXV8gfSI3Ti98fs4vj9fDIVfr4FUagwXAtIQKsyyG2EToqSzoJz6B-lKXolqAqyMoitk9jCiFKNrTRZQhwkAIF26LTkTkdP2G5VV_CM8bTUhZQ0VAZWQaLSMpNapmBxhQXDAXvTf2hz3aXVMD3e7NIQWwyxxQSRwc2AJT0vTB8wiioOGv-_NSY0DRY2f8nEgOntnX-IlUGL8U-Kr3qWG_zfaBAlr6DeIKUgzmhe0xif_bSThe0boCsboY5Uz_-T6gt2j446CNs-213fbOAl-jxre9AK9QG7M5rMTs5o--HT9PQ3LjgAeA
link.rule.ids 315,786,790,4521,24144,27955,27956,45618,45712
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYBLxZvlaSRu1N3EsfPgtluoFthWqN2ivVlxPJG22iZVs1sEB34BP5qZxFkJoXJAkZIodjJOxh5_jr8ZM_bGOVlEypXCalcIlapQ5KhmoTJrrc7jLO0Iskfx5FR9muv5FtvvfWGIVultf2fTW2vtrwz91xxeLBbDEwq-hts8lO1AJrvBbhIaIF7X3s8Nz0OFSbvCHOUWlN17znQkr-KsoOBD9EMw2gtCeV3vdB36bHuhg7tsx8NHPupKeI9tQXWf3Tr0E-QP2K8vl_UqP8dz_r4mzhgfYzfleF3x2beazxY-Sm7DjylmKzR8TMx1PsXS8BGtF86_5ssrwOSWrUX_DvlJ5zr9jo84Pr73zdxFCWu7BDFeUshFt8uP88rV54sfKI_oid8fstODD7P9ifALLohCheFKQAJalUFuI0QpSjoLziFASlOEJWgLsjKIrZM4xIhSjcM0WUIcJACBdohacqejR2y7qit4wnha6kJKmisDqyBRaZlJLVOwuMOM4YC97T-0uejiapiecHZmSC2G1GKCyOBhwJJeF6b3GEUbB41vcI0JTYOZzV-VYsD05s4_6pXBLuOfEl_3KjfY4GgWJa-gXqOkIM5oYdMYn_24qwubN0AsG6GRVE__U-ordnsyO5ya6cejz8_YHUrp-GzP2fbqcg0vEACt7Mu2gv8GGFcAfA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protamine+dosage+based+on+two+titrations+reduces+blood+loss+after+valve+replacement+surgery%3A+a+prospective%2C+double-blinded%2C+randomized+study&rft.jtitle=Canadian+journal+of+cardiology&rft.au=Guo%2C+Yan&rft.au=Tang%2C+Jiali&rft.au=Du%2C+Lei&rft.au=Liu%2C+Jin&rft.date=2012-09-01&rft.eissn=1916-7075&rft.volume=28&rft.issue=5&rft.spage=547&rft.epage=552&rft_id=info:doi/10.1016%2Fj.cjca.2012.03.012&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0828282X%2FS0828282X12X00059%2Fcov150h.gif